ethoxzolamide has been researched along with Bone Loss, Osteoclastic in 2 studies
Ethoxzolamide: A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.
ethoxzolamide : A sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hall, TJ | 1 |
Higgins, W | 1 |
Tardif, C | 1 |
Chambers, TJ | 1 |
Raisz, LG | 1 |
Simmons, HA | 1 |
Thompson, WJ | 1 |
Shepard, KL | 1 |
Anderson, PS | 1 |
Rodan, GA | 1 |
2 other studies available for ethoxzolamide and Bone Loss, Osteoclastic
Article | Year |
---|---|
A comparison of the effects of inhibitors of carbonic anhydrase on osteoclastic bone resorption and purified carbonic anhydrase isozyme II.
Topics: Acetazolamide; Bone Resorption; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dimethyl Sulfoxi | 1991 |
Effects of a potent carbonic anhydrase inhibitor on bone resorption in organ culture.
Topics: Acetazolamide; Animals; Bone and Bones; Bone Resorption; Calcitriol; Calcium Radioisotopes; Carbon D | 1988 |